Edwards Lifesciences Corporation: accounts_receivable
| Value | {"amount": 582200000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | current |
| Entity | Edwards Lifesciences Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:01:14.218439+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/44f79a40-d726-4408-8cbb-4c570693e4c1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001099800-22-000005Retrieved: 2026-08-19T11:01:14.218439+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001099800/accounts-receivable/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/44f79a40-d726-4408-8cbb-4c570693e4c1
History
- no predecessors — first report